INVOLVEMENT OF MU-OPIOID AND DELTA-OPIOID RECEPTORS IN THE EFFECTS OFSYSTEMIC AND LOCALLY PERFUSED MORPHINE ON EXTRACELLULAR LEVELS OF DOPAMINE, DOPAC AND HVA IN THE NUCLEUS-ACCUMBENS OF THE HALOTHANE-ANESTHETIZED RAT
Pj. Borg et Da. Taylor, INVOLVEMENT OF MU-OPIOID AND DELTA-OPIOID RECEPTORS IN THE EFFECTS OFSYSTEMIC AND LOCALLY PERFUSED MORPHINE ON EXTRACELLULAR LEVELS OF DOPAMINE, DOPAC AND HVA IN THE NUCLEUS-ACCUMBENS OF THE HALOTHANE-ANESTHETIZED RAT, Naunyn-Schmiedeberg's archives of pharmacology, 355(5), 1997, pp. 582-588
The effects of systemic and intra-accumbens infusion of morphine on th
e extracellular level of dopamine (DA) and its metabolites, DOPAC and
HVA, were investigated in the nucleus accumbens (NAcc) of halothane-an
aesthetized rats using in vivo microdialysis. Morphine in a dose of 1
or 5 mg/kg i.v. produced a significant increase (60-100% of baseline l
evels) in the extracellular level of DA for at least 3 h. Morphine at
5, but not 1 mg/kg, produced a small (10-15%) but significant reductio
n in the level of DOPAC when compared with saline in the first h follo
wing injection. Pretreatment with the preferential mu-opioid receptor
antagonist naloxone in a dose of 1 or 3 mg/kg i.p. significantly block
ed the morphine-induced changes in the extracellular levels of DA and
DOPAC. Pretreatment with the selective delta-opioid receptor antagonis
t, naltrindole, at 1 mg/kg i.p. blocked only the morphine-induced decr
ease in DA metabolism. Furthermore, in the presence of naltrindole, sy
stemic morphine induced a large and long-lasting increase in the level
of DOPAC and HVA, which was significantly higher than in rats receivi
ng combinations of saline/water + saline, saline/water + morphine and
naltrindole + saline. When applied directly into the NAcc, morphine at
concentrations of 125, 250 and 500 ng infused over 10 min produced a
dose-related increase in the extracellular level of accumbens DA with
either no effect or a small reduction in the level of DOPAC and HVA. T
he effects of intra-accumbens morphine on DA levels were significantly
blocked by pretreatment with i.p. naltrindole but not naloxone. These
results indicate that, while systemic morphine probably increases DA
via activation of mu-opioid receptors, local perfusion of morphine inc
reases DA in the NAcc via activation of delta-opioid receptors located
in the NAcc. Furthermore, under the conditions of the study, it appea
rs that activation of mu- and delta-opioid receptors by morphine respe
ctively increases and decreases DA metabolism.